These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28922658)

  • 41. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is it feasible to identify preterm infants with respiratory distress syndrome for early extubation to continuous positive airway pressure post-surfactant treatment during retrieval?
    Priyadarshi A; Quek WS; Luig M; Lui K
    J Paediatr Child Health; 2015 Mar; 51(3):321-7. PubMed ID: 25196918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimally invasive surfactant therapy failure: risk factors and outcome.
    Janssen LC; Van Der Spil J; van Kaam AH; Dieleman JP; Andriessen P; Onland W; Niemarkt HJ
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F636-F642. PubMed ID: 31036700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors and Outcomes of Early Intubation in Infants Born at 28-36 Weeks of Gestation Receiving Noninvasive Respiratory Support.
    Roberts CT; Owen LS; Frøisland DH; Doyle LW; Davis PG; Manley BJ
    J Pediatr; 2020 Jan; 216():109-116.e1. PubMed ID: 31610936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
    Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
    Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and Outcome of CPAP Failure in Preterm Infants.
    Dargaville PA; Gerber A; Johansson S; De Paoli AG; Kamlin CO; Orsini F; Davis PG;
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27365307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.
    Hütten MC; Kuypers E; Ophelders DR; Nikiforou M; Jellema RK; Niemarkt HJ; Fuchs C; Tservistas M; Razetti R; Bianco F; Kramer BW
    Pediatr Res; 2015 Dec; 78(6):664-9. PubMed ID: 26322413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-Effectiveness Analysis of Nasal Continuous Positive Airway Pressure Versus Nasal High Flow Therapy as Primary Support for Infants Born Preterm.
    Huang L; Roberts CT; Manley BJ; Owen LS; Davis PG; Dalziel KM
    J Pediatr; 2018 May; 196():58-64.e2. PubMed ID: 29550238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants.
    Iyer NP; Mhanna MJ
    World J Pediatr; 2014 Aug; 10(3):204-10. PubMed ID: 25124970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is it safer to intubate premature infants in the delivery room?
    Aly H; Massaro AN; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of continuous positive airway pressure in preterm babies with respiratory distress syndrome: a report from Baghdad, Iraq.
    Hameed NN; Abdul Jaleel RK; Saugstad OD
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):629-32. PubMed ID: 23885695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nasal intermittent positive pressure ventilation with or without very early surfactant therapy for the primary treatment of respiratory distress syndrome.
    Duman N; Tüzün F; Sever AH; Arslan MK; İşcan B; Dilek M; Kumral A; Ozkan H
    J Matern Fetal Neonatal Med; 2016; 29(2):252-7. PubMed ID: 25491882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
    Wright CJ; Polin RA
    Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prophylactic CPAP versus therapeutic CPAP in preterm newborns of 28-32 gestational weeks].
    Zaharie G; Ion DA; Schmidt N; Popa M; Kudor-Szabadi L; Zaharie T
    Pneumologia; 2008; 57(1):34-7. PubMed ID: 18543659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial.
    Pan R; Chen GY; Wang J; Zhou ZX; Zhang PY; Chang LW; Rong ZH
    Curr Med Sci; 2021 Jun; 41(3):542-547. PubMed ID: 34129204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
    Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
    Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome.
    Sai Sunil Kishore M; Dutta S; Kumar P
    Acta Paediatr; 2009 Sep; 98(9):1412-5. PubMed ID: 19523049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early CPAP versus surfactant in extremely preterm infants.
    ; Finer NN; Carlo WA; Walsh MC; Rich W; Gantz MG; Laptook AR; Yoder BA; Faix RG; Das A; Poole WK; Donovan EF; Newman NS; Ambalavanan N; Frantz ID; Buchter S; Sánchez PJ; Kennedy KA; Laroia N; Poindexter BB; Cotten CM; Van Meurs KP; Duara S; Narendran V; Sood BG; O'Shea TM; Bell EF; Bhandari V; Watterberg KL; Higgins RD
    N Engl J Med; 2010 May; 362(21):1970-9. PubMed ID: 20472939
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.